Investing.com - Financial Markets Worldwide

Chabiotech Co Ltd (085660)

KOSDAQ
Currency in KRW
10,830
-240(-2.17%)
Closed·
085660 Scorecard
Full Analysis
Quickly burning through cash
085660 is included in our AI-picked strategies. See how they work
Fair Value
Unlock Value
Day's Range
10,76011,140
52 wk Range
9,26018,500
Key Statistics
Edit
Bid/Ask
10,830.00 / 10,840.00
Prev. Close
11,070
Open
11,090
Day's Range
10,760-11,140
52 wk Range
9,260-18,500
Volume
201.08K
Average Volume (3m)
358.19K
1-Year Change
-29.65%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
085660 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 6
Prominent player in the Healthcare Providers & Services industry
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Chabiotech Co Ltd Company Profile

Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally. The company provides an umbilical cord blood consignment storage for the treatment of incurable diseases; regenerative medicines, immune cell and stem cell storage services, anti-aging, and solutions for incurable diseases; medical wellness programs, comprising fitness, spa, and scupplements; and customized development, production, clinical, and commercialization services to customers with research and development, and clinical experience. It offers optimized IT system construction and operation; consulting services for development, operation, and expansion of Chaum model; and solutions for maternal-centered genome testing and personalized healthcare. In addition, the company develops immune cells, such as CBT101 for recurrent glioblastoma and solid cancer, and CBT111 and CAR-NK for solid cancer; and stem cells, including CordSTEM-DD for chronic back pain, CordSTEM-POI for premature ovarian failure, CordSTEM-ST for stroke, CBT-NPC for Parkinson’s disease, and hESC-RPE for macular degeneration and Stargardt’s disease. Further, it offers IVF (fertility) services; cosmetics and cosmetic raw materials; medical devices and supplies; bioinsurance storage; research services; and other services. The company was founded in 2002 and is headquartered in Seoul, South Korea.

Industry
Healthcare Providers & Services
Sector
Healthcare
Employees
278
Market
South Korea

Compare 085660 to Peers and Sector

Metrics to compare
085660
Peers
Sector
Relationship
P/E Ratio
−59.3x−1.2x−0.5x
PEG Ratio
−1.200.010.00
Price/Book
2.9x1.3x2.6x
Price / LTM Sales
0.8x2.2x3.3x
Upside (Analyst Target)
-60.7%43.4%
Fair Value Upside
Unlock5.3%7.1%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-374.00 / --
Revenue / Forecast
304.14B / --
EPS Revisions
a
a
Unlock
Last 90 days

085660 Income Statement

People Also Watch

HMM
23,000
011200
-0.86%
Hyundai Elevator
85,500
017800
+3.39%
Doosan Heavy Ind. & Const.
66,400
034020
+1.53%
Exelixis
37.39
EXEL
-0.85%
Kia Corp
101,900
000270
+0.10%

FAQ

What Stock Exchange Does Chabiotech Trade On?

Chabiotech is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Chabiotech?

The stock symbol for Chabiotech is "085660."

What Is the Chabiotech Market Cap?

As of today, Chabiotech market cap is 846.04B.

What Is Chabiotech's Earnings Per Share (TTM)?

The Chabiotech EPS (TTM) is -255.14.

From a Technical Analysis Perspective, Is 085660 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Chabiotech Stock Split?

Chabiotech has split 3 times.

How Many Employees Does Chabiotech Have?

Chabiotech has 278 employees.

What is the current trading status of Chabiotech (085660)?

As of 08 Aug 2025, Chabiotech (085660) is trading at a price of 10,830.00, with a previous close of 11,070.00. The stock has fluctuated within a day range of 10,760.00 to 11,140.00, while its 52-week range spans from 9,260.00 to 18,500.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.